HLA-C and melanoma: Prior work has shown that BRAF inhibition increases expression of melanoma‐associated antigens by melanoma cells [30], and our gene expression data also show increased expression of Class I MHC and Class II MHC in the TIME, which could be due to enhanced expression of MHC by melanoma cells, or the increase of T cells expressing both MHC Class I and II alleles.